Premium
Private equity investors Carlyle, Signet Healthcare and OrbiMed Advisors have partially exited their investment in pharmaceutical firm Claris Lifesciences participating in the company’s buyback offer.While Carlyle backed the firm eight years ago and made modest returns over a long holding period, the other investors picked shares through open market transactions ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
